Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Spoken like a true long! Keep focused on the science! Ipix will have it's day soon.
Lmao! That's a good one! Thanks for make me laugh!
Lol! Visiting less? Closed your position?
Awesome thanks for posting!
But wouldn't you need to subtract the competitions market share? Oh yeah there is no competition!
B-OM is worth at least $10 billion!
Complaining and whining isn't the same as moving the trials forward!
I agree Dr. B wasn't given the shares for nothing. Dr. B has done a great job progressing the science which hopefully will mean a partnership soon.
Sox any idea what break-through designation will do for us and what is the timing?
And again you are purposely missing her piont. They didn't pull the numbers from thin air they used last year's. Are they contractually obligated, no but that's where they got the numbers.
Thanks for posting. I think B-OM will be our a multi- billion $ drug very quickly.
21
• Leverage 2017 Milestones to Support Partnering Opportunities
• Multiple CDAs Signed, Ongoing Interactions with Big Pharma and other Global Rx Companies
• Advance Formulation Work to Tailor Drug Delivery
• Continue to Build Value by Addressing Areas of Unmet Medical Need for
the Benefit of Patients and Shareholders
• Anchor Each Drug Candidate in Additional Trials to Further Provide
Favorable Return-On-Investment
Innovation Pharmaceuticals Strategic Direction
Of course it can be approved for any thing. My point is that it was a part of the agreement that it had to be approved for B-abbssi.
Ok since you won't answer I will. Anti-inflammatory! And imagine if the drugs we are developing have both anti-inflammatory and antibiotic properties! Seems like those could be very valuable.
Which is a more lucrative market antibiotic or anti-inflammatory?
Please you should know this! We can now accurately claim B-OM and B-up are both anti-inflammatory and have antibiotic properties! We know this because of the B-abbssi trial!
Scotty, which is a more lucrative market the antibiotic or the ant-inflammatory? 3 guesses 1st two don't count!
The application they were testing was for a possible coating which could only be done if and when it was approved as an antibiotic which we know is not the most profitable indication.
Complete B'S!
Ipix should have better special advisors!
"Yea q3 for K results is realistic really." Absolutely pure speculation! You have no idea where they are with recruitment for the trial. Very irresponsible!
In case you haven't picked up on this...there are other companies with competing trials. If you want the trial to go faster you must open more sites. That's the answer. Every trial will have competition.
I agree. I think B-OM could be a billion $ drug very quickly.
What is the pr on Monday going to be about?
I also believe it speaks to the wisdom our management showed when they decided to spend our money proving out the anti-inflammatory properties of B instead of just going after the antibiotic indication.
Exactly. That's the money quote.
Great article about the potential for a drug that could be used for cardivacular disease that ha both antiinflamatory and antibiotic properties. http://wapo.st/2vr1Yhn?tid=ss_mail&utm_term=.57132b910af8
My recollection is that it would be a very expensive trial process but also very difficult. I would imagine at some point the drug would need to be tested on children which would not be easy.
Sox, am i correct to assume the following about the current P trial?
1. The dose increased from 200mg to 300mg.
2. The patient population for the trial got easier(mild to moderate v moderate to severe).
3. The scale used for the trial is easier than the phase 2a.
Because when we get a partnership one of the first things we will do is uplist!! I take this as a good sign.
Disagree completely. He has moved the science along very well. Without science we wont have a chance at partnership which is the goal. BP isnt partnering for our sp they want the science!
In a pre-revenue biotech job 1 is to move the science forward. Leo has done a great job at that!
He is a master at it!;)
It's a very well respected Ivy league hospital. I am sure if they didn't believe in the science they wouldn't have agreed to subject their patients to the trial.
He Said the end of the third quarter. That's the expectation.
He already advised you that it would be by the end of the third quarter which is the end of September. All your trying to do is create false expectations.
If they have no credibility then why did another prestigious institution sign up to run a trial?
The fundamentals are the science. It's all about the science! We have no revenues. Check yourself by calling your contact in sales!
Dartmouth is an ivy league school. Very good reputation.
Seems like the new location is probably: Dartmouth-Hitchcock